StockNews.com Begins Coverage on Bellerophon Therapeutics (NASDAQ:BLPH)

StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report released on Friday. The firm issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Stock Performance Shares of NASDAQ BLPH opened at $0.05 on Friday. The company has a market cap of $623,730.00, a price-to-earnings ratio of […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Lowers CNB Financial (NASDAQ:CCNE) to Hold
Next post Head to Head Comparison: Urgent.ly (ULY) & Its Rivals